Celesio, one of the leading international service providers in the pharmaceutical and healthcare markets, Thursday announced the acquisition of 60 per cent of the Brazilian Oncoprod Group, São Paulo. Oncoprod is the leading wholesaler for specialty pharmaceuticals in Brazil.
“The Brazilian pharma market offers many opportunities for growth,” noted Markus Pinger, Chairman of the Management Board [...]

Actavis Group CEO Claudio Albrecht Wednesday announced a major sales expansion into Latin America, among the world’s fastest-growing markets for generic drugs.
Albrecht outlined the company’s growth strategy at a meeting in South Florida with Actavis’ new Latin American business unit. The Latin America team, based in Sunrise, Florida, will target Brazil, Argentina, Colombia, Mexico, Venezuela [...]

Arseus announced Monday that it has signed an agreement for the acquisition of the Brazilian Pharma Nostra, a leading supplier of raw materials for pharmaceutical compounding to pharmacies in Brazil.
Pharma Nostra is the market leader in Brazil with a turnover of approximately € 45 million in 2010.
Pharma Nostra’s EBITDA margin is approximately 15%. The acquisition [...]

Amgen, the world’s largest biotechnology company, has expanded its operations in Brazil through the acquisition of Bergamo, a privately-held Brazilian pharmaceutical company. In addition, Amgen has also agreed to reacquire rights in Brazil to its products that were previously granted to Mantecorp (subsequently acquired by Hypermarcas).
Kevin Sharer, Amgen’s chairman and chief executive officer said Amgen’s [...]

Gerresheimer AG has acquired Vedat, a major Brazilian manufacturer of pharmaceutical plastic packaging products, especially plastic closures. Gerresheimer AG is one of the leading worldwide suppliers to the pharma and healthcare industry. The investment is aimed at strengthening its pharmaceutical plastic packaging business in South America. The financial details of the transaction were not disclosed.
Uwe [...]

Eurofarma Laboratorios Ltda acquired the entire share capital of Segmenta Farmaceutica Ltda (Segmenta), a Sao Paulo-based manufacturer of pharmaceuticals. Terms of the investment were however not disclosed. On completion, Segmenta will be renamed Eurofarma Segmenta.
The Brazilian generic drug maker Eurofarma said the investment is geared at reinforcing its expansion plans with the acquisition of Segmenta. [...]

US based pharmaceuticals major Pfizer Inc Thursday announced it has entered a partnership with Brazil’s foremost generics industry firm for the manufacture of generic medicines. In its announcement, Pfizer said it had agreed on a partnership with Laboratorio Teuto Brasileiro S.A, Brazil’s leading firm in the country’s generics industry, to develop and commercialize generic medicines.
Under [...]